Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Been looking at marijuana stocks today and honestly, most of them are kind of a mess. Tilray keeps getting hyped, but when you dig into the numbers, it's actually kind of a cautionary tale.
So Tilray started as a pure play cannabis company, right? But that didn't work out financially, so management pivoted hard. They went on an acquisition spree, buying up brands across weed, CBD, and alcohol. Sounds smart in theory. Problem is, they've been funding all these deals with stock, which absolutely destroyed shareholders. The share count exploded over 300% in just five years, and they still haven't figured out how to be profitable. They've even taken impairment charges across basically every segment. That's... not great.
Here's the thing though - if you're looking at marijuana stocks today and want something with actual cash flow and a proven business model, Altria might be the smarter play. Yeah, I know, it's a tobacco company, which sounds boring and risky. But that's kind of the point.
Marlboro has 40.5% of the US cigarette market. Overall, Altria controls 45.2% of cigarettes. That's a massive moat. Sure, cigarette volumes are declining - that's the real risk here. But the business still prints cash like crazy. That cash is funding a 6.1% dividend and getting plowed into new products they hope will eventually replace cigarettes.
Altria's made mistakes, no question. Their Juul investment bombed. They tried marijuana stocks today and that flopped too. Billions in write-offs. But they were strong enough to absorb those losses and keep swinging. They just bought NJOY, another vape play. That's the difference - Altria has the financial firepower to fail and try again.
With Tilray, you're betting that management suddenly figures out a sustainable business model. With Altria, you're getting paid a solid yield while they transition their business. The core business is declining, sure, but it's still a cash cow. That's way less risky than gambling on marijuana stocks today turning profitable.
Don't get me wrong - both are risky. But if you're going to take that risk, Altria has way better risk-reward. Just watch the business closely to see how management is offsetting those cigarette declines. That's the real tell.